Medical Technology, School of Allied Health Sciences, Walailak University, Tha Sala, Nakhon Si Thammarat, Thailand.
Department of Medical Technology, Institute of Arts and Sciences, Far Eastern University-Manila, Manila, Philippines.
Infect Dis Poverty. 2020 Sep 22;9(1):134. doi: 10.1186/s40249-020-00741-z.
Co-infection with both Plasmodium and dengue virus (DENV) infectious species could have serious and fatal outcomes if left undiagnosed and without timely treatment. The present study aimed to determine the pooled prevalence estimate of severe malaria among patients with co-infection, the risk of severe diseases due to co-infection, and to describe the complications of severe malaria and severe dengue among patients with co-infection.
Relevant studies published between databases between 12 September 1970 and 22 May 2020 were identified and retrieved through a search of the ISI Web of Science, Scopus, and MEDLINE. The pooled prevalence and 95% confidence interval (CI) of severe malaria among patients with Plasmodium and DENV co-infection was estimated with a random-effects model to take into account the between-study heterogeneity of the included studies. The risks of severe malaria and severe diseases due to co-infection were estimated with the pooled odds ratio (OR) and 95% CI with a random-effects model.
Of the 5653 articles screened, 13 studies were included in the systematic review and meta-analysis. The results demonstrated that the pooled prevalence estimate of severe malaria among patients with co-infection was 32% (95% CI: 18-47%, I = 92.3%). Patients with co-infection had a higher risk of severe diseases than those with DENV mono-infection (odds ratio [OR] = 3.94, 95% CI: 1.96-7.95, I = 72%). Patients with co-infection had a higher risk of severe dengue than those with DENV mono-infection (OR = 1.98, 95% CI: 1.08-3.63, I = 69%). The most severe complications found in severe dengue were bleeding (39.6%), jaundice (19.8%), and shock/hypotension (17.9%), while the most severe complications found in severe malaria were severe bleeding/bleeding (47.9%), jaundice (32.2%), and impaired consciousness (7.43%).
The present study found that there was a high prevalence of severe malaria among patients with Plasmodium and DENV co-infection. Physicians in endemic areas where these two diseases overlap should recognize that patients with this co-infection can develop either severe malaria or severe dengue with bleeding complications, but a greater risk of developing severe dengue than severe malaria was noted in patients with this co-infection.
The protocol of this study was registered at PROSPERO: CRD42020196792 .
如果未得到诊断和及时治疗,同时感染疟原虫和登革热病毒(DENV)会导致严重和致命的后果。本研究旨在确定合并感染患者中严重疟疾的合并患病率估计值、合并感染导致严重疾病的风险,并描述合并感染患者中严重疟疾和严重登革热的并发症。
通过检索 ISI Web of Science、Scopus 和 MEDLINE 数据库,确定并检索了 1970 年 9 月 12 日至 2020 年 5 月 22 日期间发表的相关研究。使用随机效应模型估计合并感染的疟原虫和 DENV 患者中严重疟疾的合并患病率和 95%置信区间(CI),以考虑纳入研究之间的异质性。使用随机效应模型估计合并感染患者中严重疟疾和严重疾病的风险的合并优势比(OR)和 95%CI。
在筛选的 5653 篇文章中,有 13 项研究纳入了系统评价和荟萃分析。结果表明,合并感染患者中严重疟疾的合并患病率估计值为 32%(95%CI:18-47%,I=92.3%)。合并感染患者发生严重疾病的风险高于 DENV 单感染患者(比值比[OR] =3.94,95%CI:1.96-7.95,I=72%)。合并感染患者发生严重登革热的风险高于 DENV 单感染患者(OR=1.98,95%CI:1.08-3.63,I=69%)。严重登革热最严重的并发症为出血(39.6%)、黄疸(19.8%)和休克/低血压(17.9%),严重疟疾最严重的并发症为严重出血/出血(47.9%)、黄疸(32.2%)和意识障碍(7.43%)。
本研究发现,疟原虫和 DENV 合并感染患者中严重疟疾的患病率较高。在这两种疾病重叠的流行地区,医生应认识到,此类合并感染的患者可能会发生严重疟疾或严重登革热伴有出血并发症,但与严重疟疾相比,此类合并感染的患者发生严重登革热的风险更高。
本研究方案在 PROSPERO 注册:CRD42020196792。